Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL
This study has been withdrawn prior to enrollment.
(Funding will not be provided for the drug)
Sponsor:
Alberta Health Services
Information provided by:
Alberta Health Services
ClinicalTrials.gov Identifier:
NCT00414089
First received: December 19, 2006
Last updated: February 8, 2010
Last verified: July 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |